Similar articles

• [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].

  Bouza E, Rodríguez-Créixems M, Muñoz P. Bouza E, et al. Rev Clin Esp. 1997 Sep;197 Suppl 2:52-8. Rev Clin Esp. 1997. PMID: 9441324 Review. Spanish. No abstract available.
• Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.

  Lefort A, Arthur M, Depardieu F, Chau F, Pouzet C, Courvalin P, Fantin B. Lefort A, et al. J Infect Dis. 2004 Jan 1;189(1):90-7. doi: 10.1086/380566. Epub 2003 Dec 22. J Infect Dis. 2004. PMID: 14702158
• Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.

  Hung YP, Lee NY, Chang CM, Lee HC, Wu CJ, Chen PL, Lee CC, Chung CH, Ko WC. Hung YP, et al. Clin Ther. 2009 Sep;31(9):1977-86. doi: 10.1016/j.clinthera.2009.09.010. Clin Ther. 2009. PMID: 19843487
• [Streptogramins and glycopeptides].

  Tsuji A. Tsuji A. Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:360-6. Nihon Rinsho. 2007. PMID: 17455646 Review. Japanese. No abstract available.
• [Enterococcal endocarditis, a model of therapeutic difficulty].

  Fernández Guerrero ML, Núñez García A. Fernández Guerrero ML, et al. Rev Clin Esp. 1995 Oct;195 Suppl 4:41-5. Rev Clin Esp. 1995. PMID: 9441316 Review. Spanish. No abstract available.